Universität Wien
Achtung! Das Lehrangebot ist noch nicht vollständig und wird bis Semesterbeginn laufend ergänzt.

320056 VO Innovation und Leadership (2016S)

1.00 ECTS (2.00 SWS), SPL 32 - Pharmazie

Course Dates (SS2016): 06 April - 13 May 2016
Je. Mi. 18.30 - 20.30 Uhr s.t. 06.04*, 13.04, 20.04, 27.04, 04.05, 11.05
Je. Fri. 17.00 - 19.00 Uhr s.t. 08.04*, 15.04, 22.04, 29.04, 06.05, 13.05
(* Mi. 06.04 18.30 - 20.00 Uhr s.t & Fri. 08.04 17.00 - 18.30 Uhr s.t.)

Immer Seminarraum 2D313, UZA II
Moodle

Details

Sprache: Englisch

Prüfungstermine

Lehrende

Termine (iCal) - nächster Termin ist mit N markiert

  • Mittwoch 30.03. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Freitag 01.04. 17:00 - 19:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Mittwoch 06.04. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Freitag 08.04. 17:00 - 19:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Mittwoch 13.04. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Freitag 15.04. 17:00 - 19:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Mittwoch 20.04. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Freitag 22.04. 17:00 - 19:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Mittwoch 27.04. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Freitag 29.04. 17:00 - 19:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Mittwoch 04.05. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Freitag 06.05. 17:00 - 19:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II

Information

Ziele, Inhalte und Methode der Lehrveranstaltung

The pharmaceutical industry has produced impressive breakthrough medicines such as, insulin, first in class vaccines, antibiotics, retroviral and cancer therapies that have significantly impacted our society. Furthermore, rapid advances in technology, and infrastructure have resulted due to advancing R & D needs throughout the evolving process of designing new therapies. However, the industry has been criticized during the last decade for its lack of innovation. What exactly does ‘lack of innovation’ mean? Clearly the need to ‘be innovative’ is obvious. However, the process of finding novel solutions to problems, recognizing good ideas that meet needs and produce disruptive technologies or services to the market is extremely challenging.

Art der Leistungskontrolle und erlaubte Hilfsmittel

Mindestanforderungen und Beurteilungsmaßstab

This course will introduce the concept of innovation and disruptive technology as well as review exemplary innovators in health care?and other industries. Armed with this?knowledge, students will interactively experience the process of innovation in the context of a project related to pharmaceutical science that will provide a framework to explore the unique leadership competencies required to guide and shape creative teams and inspire the imagination needed to recognize a good idea and transform it into a useful or even disruptive technology. This course is in English and fulfills 1 ECTS.

Prüfungsstoff

Literatur

Zuordnung im Vorlesungsverzeichnis

A 400

Letzte Änderung: Sa 02.04.2022 00:27